Elan’s Drug Technology group focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.  We offer our clients unrivalled expertise with a suite of commercially launched, proprietary, technology-driven solutions.  From NanoCrystal® Technology for poorly water soluble compounds to customized oral drug technologies we have a proud track record of innovation and experience.  Today, more than 3.2 million patients worldwide use drug products based on or enhanced by our technologies.



 

 

 
 

Rapamune®

Case Study 1

Improving Patient Compliance and Convenience with NanoCrystal® Technology
» More Information

Megace® ES

Case Study 2

Enhanced Patient Acceptability Creating a Branded Opportunity
» More Information

Avinza®

Case Study 3

Once Daily, Novel Dual Release Morphine Sulphate
» More Information

Verelan® PM

Case Study 4

Once daily, night-time dosed antihypertensive to minimize cardio events
» More Information

Copyright © 2001- 2007 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use | Site Map | Contact Us